CYTODRIVE Trademark
Trademark Overview
On Thursday, December 8, 2022, a trademark application was filed for CYTODRIVE with the United States Patent and Trademark Office. The USPTO has given the CYTODRIVE trademark a serial number of 97708951. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 4, 2025. This trademark is owned by Obsidian Therapeutics, Inc.. The CYTODRIVE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations in the field of cell and gene therapies for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders
General Information
| Serial Number | 97708951 |
| Word Mark | CYTODRIVE |
| Filing Date | Thursday, December 8, 2022 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, August 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 7, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations in the field of cell and gene therapies for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 5, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Obsidian Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02138 |
| Party Name | Obsidian Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02138 |
Trademark Events
| Event Date | Event Description |
| Monday, December 12, 2022 | NEW APPLICATION ENTERED |
| Thursday, January 5, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 14, 2023 | ASSIGNED TO EXAMINER |
| Monday, October 2, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 18, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 7, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 2, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, June 27, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 27, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, November 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, December 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 5, 2024 | SOU EXTENSION 2 FILED |
| Friday, December 6, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, June 27, 2024 | SOU EXTENSION 1 GRANTED |
| Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 4, 2025 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, August 4, 2025 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
